Effect of glucoprivation on serotonin neurotoxicity induced by substituted amphetamines

J Pharmacol Exp Ther. 2002 Nov;303(2):831-9. doi: 10.1124/jpet.102.041277.

Abstract

The present studies were conducted to further explore the potential role of metabolic compromise in substituted amphetamine-induced serotonin (5-HT) neurotoxicity. To this end, we examined the glucoprivic effects of 2-deoxy-D-glucose (2-DG) on the 5-HT neurotoxic effects of fenfluramine (FEN) and methylenedioxymethamphetamine (MDMA). Rats were treated with either FEN or MDMA, alone and in combination, with doses of 2-DG known to produce glucoprivic effects at either 22 +/- 1 or 28 +/- 1 degrees C. At 22 +/- 1 degrees C, FEN produced hypothermia, MDMA induced hyperthermia, and both drugs produced significant long-term reductions in regional brain 5-HT neuronal markers. 2-DG did not enhance 5-HT neurotoxicity induced by either FEN or MDMA; indeed, in some instances, it afforded partial neuroprotection. Although 2-DG afforded partial protection from both FEN and MDMA-induced 5-HT neurotoxic changes, it also caused significant hypothermia, raising the possibility that protection was due to a lowered temperature. Increasing the ambient temperature to 28 +/- 1 degrees C largely eliminated drug-induced hypothermia and eliminated the neuroprotective effects of 2-DG. Thus, even without the confounding effect of temperature, 2-DG still did not potentiate FEN or MDMA-induced 5-HT neurotoxicity. These findings suggest that the role of metabolic compromise in amphetamine-induced 5-HT neurotoxicity merits further study.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amphetamines / toxicity*
  • Animals
  • Antimetabolites / pharmacology
  • Biogenic Monoamines / metabolism
  • Body Temperature / physiology
  • Carrier Proteins / metabolism
  • Deoxyglucose / pharmacology
  • Energy Metabolism / drug effects
  • Fenfluramine / pharmacology
  • Glucose / physiology*
  • Hydroxyindoleacetic Acid / metabolism
  • Male
  • Membrane Glycoproteins / metabolism
  • Membrane Transport Proteins*
  • N-Methyl-3,4-methylenedioxyamphetamine / pharmacology
  • Nerve Degeneration / chemically induced
  • Nerve Degeneration / prevention & control
  • Nerve Tissue Proteins*
  • Rats
  • Rats, Sprague-Dawley
  • Selective Serotonin Reuptake Inhibitors / pharmacology
  • Serotonin / metabolism
  • Serotonin / toxicity*
  • Serotonin Agents / pharmacology
  • Serotonin Plasma Membrane Transport Proteins

Substances

  • Amphetamines
  • Antimetabolites
  • Biogenic Monoamines
  • Carrier Proteins
  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • Serotonin Agents
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Uptake Inhibitors
  • Slc6a4 protein, rat
  • Fenfluramine
  • Serotonin
  • Hydroxyindoleacetic Acid
  • Deoxyglucose
  • Glucose
  • N-Methyl-3,4-methylenedioxyamphetamine